Interleukin-1 inhibitors

Abstract From the Canadian patent

IL-1 inhibitors are provided. According to certain embodiments, the IL-1 inhibitors comprise an amino acid sequence selected from:, (i) all or an IL-1 inhibitory fragment of the following amino acid sequence:, (U) (X) P S G R X S S K M Q A F R I W D V N Q K T F Y L R N N Q L V A G Y L Q G P N V N L E E R I D V V P I E P H A L F L G I H D d K M C L S C V R S G D E T R L Q L E A V N I T D L S E N R K Q D K R F A F I R S D S G P T T S F E S A A C P G W F L C T A M E A D Q P V S L T N M B D E G V M V T R F Y F Q E D E, wherein (U) is nothing M, or comprises an N-, terminal leader sequence and (X) is R or P; or (ii) an amino acid sequence that is at least 70 % homologous to the amino acid …